drugset / Trial / NCT02679235
Brain Energy and Aging With Triheptanoin
Phase 1/2
Completed
15 enrolled
University of Sherbrooke
Fonds de la Recherche en Santé du Québec · collabUltragenyx Pharmaceutical Inc · collab
NaSingle-groupOpen-labelTreatment
Summary
BEAT7-001 is a single group study (supplementation). Using a multi-modal brain imaging portfolio, this study will assess whether brain energy metabolism (glucose and ketones), structure or functional connectivity change in older people with frontal glucose hypometabolism after 28 days on an oral dose of 1 g/kg/day of triheptanoin.
Timeline
- Start
- 2016-04
- Primary completion
- 2018-08-08
- Completion
- 2018-08-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triheptanoin | Other / unclassified | 1 g/kg | Oral |
Indications
No indication recorded.